ProfileGDS5822 / ILMN_1252778
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 40% 1% 19% 28% 39% 33% 2% 29% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 118.240
GSM1276600PDAC Late Ablation Control 26.81
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 11119
GSM1276603PDAC Late Ablation 214.428
GSM1276604PDAC Late Ablation 31939
GSM1303940PDAC Late Ablation_anti-CTLA4 116.433
GSM1303941PDAC Late Ablation_anti-CTLA4 21.92
GSM1303942PDAC Late Ablation_anti-CTLA4 314.429